CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera

Dow Jones

Yesterday

By Adriano Marchese

CapsoVision shares rose after the company said it has submitted to U.S. health regulators its new artificial-intelligence-assisted reading tool for its CapsoCam Plus endoscopy system, which uses a swallowable camera.

Shares rose 11% to $12.91 midday Tuesday.

The commercial-stage medical-technology company said late Monday that it has submitted an application to the Food and Drug Administration for its proprietary AI-assisted module for its CapsoCam Plus.

CapsoVision said the addition of this reading tool will improve the detection of clinically significant pathology, and can help doctors spot small-bowel problems more accurately and review images more quickly.

Once it receives regulatory clearance, the Saratoga, Calif., company intends to begin U.S. commercialization activities, it said.

Write to Adriano Marchese at adriano.marchese@wsj.com

(END) Dow Jones Newswires

December 30, 2025 11:57 ET (16:57 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2595716293"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2595716293\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2595716293?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 00:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2595716293","market":"hk","top_or_hot":-1,"title":"CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  CapsoVision shares rose after the company said it has submitted to U.S. health regulators its new artificial-intelligence-assisted reading tool for its CapsoCam Plus endoscopy system, which uses a swallowable camera. \n</p>\n<p>\n  Shares rose 11% to $12.91 midday Tuesday. \n</p>\n<p>\n  The commercial-stage medical-technology company said late Monday that it has submitted an application to the Food and Drug Administration for its proprietary AI-assisted module for its CapsoCam Plus. \n</p>\n<p>\n  CapsoVision said the addition of this reading tool will improve the detection of clinically significant pathology, and can help doctors spot small-bowel problems more accurately and review images more quickly. \n</p>\n<p>\n  Once it receives regulatory clearance, the Saratoga, Calif., company intends to begin U.S. commercialization activities, it said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 11:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCapsoVision Shares Rise on FDA Application for AI Tool in Swallowable Camera\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-12-31 00:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Adriano Marchese \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  CapsoVision shares rose after the company said it has submitted to U.S. health regulators its new artificial-intelligence-assisted reading tool for its CapsoCam Plus endoscopy system, which uses a swallowable camera. \n</p>\n<p>\n  Shares rose 11% to $12.91 midday Tuesday. \n</p>\n<p>\n  The commercial-stage medical-technology company said late Monday that it has submitted an application to the Food and Drug Administration for its proprietary AI-assisted module for its CapsoCam Plus. \n</p>\n<p>\n  CapsoVision said the addition of this reading tool will improve the detection of clinically significant pathology, and can help doctors spot small-bowel problems more accurately and review images more quickly. \n</p>\n<p>\n  Once it receives regulatory clearance, the Saratoga, Calif., company intends to begin U.S. commercialization activities, it said. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 30, 2025 11:57 ET (16:57 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2595716293","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2595716293","pubTimestamp":1767113820,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"CapsoVision shares rose after the company said it has submitted to U.S. health regulators its new artificial-intelligence-assisted reading tool for its CapsoCam Plus endoscopy system, which uses a swallowable camera.The commercial-stage medical-technology company said late Monday that it has submitted an application to the Food and Drug Administration for its proprietary AI-assisted module for its CapsoCam Plus.CapsoVision said the addition of this reading tool will improve the detection of clinically significant pathology, and can help doctors spot small-bowel problems more accurately and review images more quickly.Once it receives regulatory clearance, the Saratoga, Calif., company intends to begin U.S. commercialization activities, it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","CV":"CapsoVision, Inc."},"translate_title":"CapsoVision股价因FDA申请可吞咽相机中的人工智能工具而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CV":1.5},"content_text":"By Adriano Marchese \n\n\n \n\n\n  CapsoVision shares rose after the company said it has submitted to U.S. health regulators its new artificial-intelligence-assisted reading tool for its CapsoCam Plus endoscopy system, which uses a swallowable camera. \n\n\n  Shares rose 11% to $12.91 midday Tuesday. \n\n\n  The commercial-stage medical-technology company said late Monday that it has submitted an application to the Food and Drug Administration for its proprietary AI-assisted module for its CapsoCam Plus. \n\n\n  CapsoVision said the addition of this reading tool will improve the detection of clinically significant pathology, and can help doctors spot small-bowel problems more accurately and review images more quickly. \n\n\n  Once it receives regulatory clearance, the Saratoga, Calif., company intends to begin U.S. commercialization activities, it said. \n\n\n \n\n\n  Write to Adriano Marchese at adriano.marchese@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 30, 2025 11:57 ET (16:57 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}